Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12293 | 917 | 31.3 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
176 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 58057 |
79 | 2 | DIABETES CARE//DIABETES EDUCATOR//DIABETIC MEDICINE | 27337 |
12293 | 1 | DIABETES RELATED COMPLICATIONS//COST OF DIABETES CARE//CARDIFF DIABETES MODEL | 917 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DIABETES RELATED COMPLICATIONS | authKW | 92479 | 1% | 28% | 10 |
2 | COST OF DIABETES CARE | authKW | 74918 | 0% | 75% | 3 |
3 | CARDIFF DIABETES MODEL | authKW | 66595 | 0% | 100% | 2 |
4 | CARDIFF MODEL | authKW | 66595 | 0% | 100% | 2 |
5 | COST OF DIABETES | authKW | 66595 | 0% | 100% | 2 |
6 | DESIGNED ABSORPTION | authKW | 66595 | 0% | 100% | 2 |
7 | FOR UNGSGRP PRIMARMED VERSORGUNG | address | 66595 | 0% | 100% | 2 |
8 | THE NATIONAL HOSPITAL AMBULATORY MEDICAL CARE SURVEY NHAMCS | authKW | 66595 | 0% | 100% | 2 |
9 | UKPDS | address | 66595 | 0% | 100% | 2 |
10 | FINANCIAL CONSEQUENCES | authKW | 49944 | 0% | 50% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 9578 | 39% | 0% | 362 |
2 | Health Care Sciences & Services | 6760 | 19% | 0% | 171 |
3 | Health Policy & Services | 6539 | 14% | 0% | 129 |
4 | Medicine, General & Internal | 2400 | 24% | 0% | 224 |
5 | Public, Environmental & Occupational Health | 848 | 14% | 0% | 124 |
6 | Economics | 355 | 8% | 0% | 70 |
7 | Primary Health Care | 136 | 1% | 0% | 12 |
8 | Medical Informatics | 134 | 2% | 0% | 15 |
9 | Pharmacology & Pharmacy | 75 | 8% | 0% | 73 |
10 | Medicine, Research & Experimental | 41 | 4% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FOR UNGSGRP PRIMARMED VERSORGUNG | 66595 | 0% | 100% | 2 |
2 | UKPDS | 66595 | 0% | 100% | 2 |
3 | MED POLICY PRACTICE | 49944 | 0% | 50% | 3 |
4 | ROYAL NEW ZEALAND GEN PRACTITIONERS UNIT | 44396 | 0% | 67% | 2 |
5 | ABORATING DIABET EXPT PL ENDOCRIN | 33298 | 0% | 100% | 1 |
6 | ABS SA A FAMILIA | 33298 | 0% | 100% | 1 |
7 | ABT GESUNDHEITSOKON OUTCOMES FOR | 33298 | 0% | 100% | 1 |
8 | ACCESS PUBL AFFAIR | 33298 | 0% | 100% | 1 |
9 | ACHORD GRP | 33298 | 0% | 100% | 1 |
10 | ANAL METHODS | 33298 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIABETIC MEDICINE | 23209 | 7% | 1% | 63 |
2 | DIABETES CARE | 20589 | 9% | 1% | 84 |
3 | PHARMACOECONOMICS | 14510 | 3% | 1% | 31 |
4 | DIABETES RESEARCH AND CLINICAL PRACTICE | 13856 | 5% | 1% | 47 |
5 | DIABETES STOFFWECHSEL UND HERZ | 10685 | 1% | 4% | 9 |
6 | JOURNAL OF MEDICAL ECONOMICS | 9131 | 1% | 3% | 8 |
7 | AMERICAN JOURNAL OF MANAGED CARE | 8887 | 3% | 1% | 27 |
8 | VALUE IN HEALTH | 7698 | 2% | 1% | 19 |
9 | DISEASE MANAGEMENT & HEALTH OUTCOMES | 7331 | 1% | 2% | 10 |
10 | JOURNAL OF DIABETES AND ITS COMPLICATIONS | 5961 | 2% | 1% | 18 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SEURING, T , ARCHANGELIDI, O , SUHRCKE, M , (2015) THE ECONOMIC COSTS OF TYPE 2 DIABETES: A GLOBAL SYSTEMATIC REVIEW.PHARMACOECONOMICS. VOL. 33. ISSUE 8. P. 811 -831 | 72 | 70% | 32 |
2 | YI, Y , PHILIPS, Z , BERGMAN, G , BURSLEM, K , (2010) ECONOMIC MODELS IN TYPE 2 DIABETES.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 26. ISSUE 9. P. 2105-2118 | 32 | 63% | 16 |
3 | VON FERBER, L , KOSTER, I , HAUNER, H , (2007) MEDICAL COSTS OF DIABETIC COMPLICATIONS TOTAL COSTS AND EXCESS COSTS BY AGE AND TYPE OF TREATMENT RESULTS OF THE GERMAN CODIM STUDY.EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. VOL. 115. ISSUE 2. P. 97 -104 | 23 | 85% | 30 |
4 | BRANDLE, M , ZHOU, HH , SMITH, BRK , MARRIOTT, D , BURKE, R , TABAEI, BP , BROWN, MB , HERMAN, WH , (2003) THE DIRECT MEDICAL COST OF TYPE 2 DIABETES.DIABETES CARE. VOL. 26. ISSUE 8. P. 2300-2304 | 20 | 91% | 137 |
5 | NG, CS , LEE, JYC , TOH, MPHS , KO, Y , (2014) COST-OF-ILLNESS STUDIES OF DIABETES MELLITUS: A SYSTEMATIC REVIEW.DIABETES RESEARCH AND CLINICAL PRACTICE. VOL. 105. ISSUE 2. P. 151 -163 | 22 | 55% | 14 |
6 | FUKUDA, H , IKEDA, S , SHIROIWA, T , FUKUDA, T , (2016) THE EFFECTS OF DIAGNOSTIC DEFINITIONS IN CLAIMS DATA ON HEALTHCARE COST ESTIMATES: EVIDENCE FROM A LARGE-SCALE PANEL DATA ANALYSIS OF DIABETES CARE IN JAPAN.PHARMACOECONOMICS. VOL. 34. ISSUE 10. P. 1005 -1014 | 16 | 80% | 0 |
7 | KOSTER, I , HUPPERTZ, E , HAUNER, H , SCHUBERT, I , (2014) COSTS OF DIABETES MELLITUS (CODIM) IN GERMANY, DIRECT PER-CAPITA COSTS OF MANAGING HYPERGLYCAEMIA AND DIABETES COMPLICATIONS IN 2010 COMPARED TO 2001.EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. VOL. 122. ISSUE 9. P. 510 -516 | 16 | 76% | 10 |
8 | PAGANO, E , BO, S , PETRINCO, M , ROSATO, R , MERLETTI, F , GREGORI, D , (2009) FACTORS AFFECTING HOSPITALIZATION COSTS IN TYPE 2 DIABETIC PATIENTS.JOURNAL OF DIABETES AND ITS COMPLICATIONS. VOL. 23. ISSUE 1. P. 1-6 | 18 | 78% | 16 |
9 | KOSTER, I , VON FERBER, L , IHLE, P , SCHUBERT, I , HAUNER, H , (2006) THE COST BURDEN OF DIABETES MELLITUS: THE EVIDENCE FROM GERMANY - THE CODIM STUDY.DIABETOLOGIA. VOL. 49. ISSUE 7. P. 1498-1504 | 15 | 88% | 105 |
10 | WARD, A , O'BRIEN, JA , SALAS, M , (2005) COST-EFFECTIVENESS OF ORAL HYPOGLYCAEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 6. ISSUE 4. P. 601-608 | 23 | 68% | 1 |
Classes with closest relation at Level 1 |